Chargement en cours...
Cardiovascular benefits of SGLT2 inhibitors in patients with heart failure: a meta-analysis of small and large randomized controlled trials
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in improving cardiovascular outcome in patients with heart failure (HF) and diabetes mellitus (DM). Although these benefits have been confirmed by several meta-analyses, small studies have not been included into these p...
Enregistré dans:
| Publié dans: | Am J Cardiovasc Dis |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8303041/ https://ncbi.nlm.nih.gov/pubmed/34322297 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|